Jens Eckstein

Jens Eckstein has more than 20 years of biopharma venture capital and company creation experience and 10 years of operational experience in drug discovery and development. Before joining Apollo Health Ventures as Managing Partner, Dr. Eckstein served as President of GlaxoSmithKline’s corporate venture fund SR One for eight years. He is also co-founder and was Managing Director of GSK’s Action Potential Venture Capital (APVC) fund, which invests in pioneering bioelectronic technologies. Previously, he was a General Partner at TVM Capital leading early-stage investments in Boston.

Dr. Eckstein is a Kauffman Fellow, a member of the EU-sponsored Gold Track Expert Council, and a passionate mentor for entrepreneurs and start-up teams in life science and healthcare IT. Before his investment career, Dr. Eckstein led research teams and pharma collaborations at Enanta Pharmaceuticals (NASDAQ: ENTA) and Mitotix, Inc.